Beacon Therapeutics Deal History & Licensing Activity
Beacon Therapeutics is a biotech headquartered in US. Over the past three years, Beacon Therapeutics has been involved in 1 licensing and acquisition transaction, with a primary focus on Gene Therapy (2 deals). The company currently has 7 active clinical trials, primarily in Ophthalmology.
Deals (12mo)
2
Active Trials
7
Top Modality
Gene Therapy
Focus Area
Ophthalmology
Beacon Therapeutics Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Beacon Therapeutics in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| AAV204 capsid | Abeona Therapeutics | Gene Therapy | Preclinical | option | Jul 2025 |
Beacon Therapeutics Pipeline Focus
Therapeutic areas and modalities where Beacon Therapeutics is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Beacon Therapeutics Strategic Signals
Key indicators of Beacon Therapeutics's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Strategic Priorities
Beacon Therapeutics Clinical Pipeline
Beacon Therapeutics has 7 active clinical trials across 2 development phases.
3
Phase 1
4
Phase 2
See How Your Asset Matches Beacon Therapeutics's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Ophthalmology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Ophthalmology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for ophthalmology
Gene Therapy Benchmarks
Upfront, milestone, and royalty benchmarks for gene therapy deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Beacon Therapeutics Licensing & Deal Activity
Beacon Therapeutics is a biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Beacon Therapeutics ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Beacon Therapeutics include Ophthalmology (2 deals and trials). In terms of modality, Beacon Therapeutics has shown particular interest in gene therapy.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Beacon Therapeutics and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Beacon Therapeutics's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.